RYZUMI Trademark

Trademark Overview


On Monday, October 10, 2022, a trademark application was filed for RYZUMI with the United States Patent and Trademark Office. The USPTO has given the RYZUMI trademark a serial number of 97626125. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, July 29, 2024. This trademark is owned by OCUPHIRE PHARMA, INC.. The RYZUMI trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical field; consulting services in the field of pharmaceutical research and development; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
ryzumi

General Information


Serial Number97626125
Word MarkRYZUMI
Filing DateMonday, October 10, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, July 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 19, 2023

Trademark Statements


Goods and ServicesResearch and development in the pharmaceutical field; consulting services in the field of pharmaceutical research and development; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 25, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOCUPHIRE PHARMA, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFarmington Hills, MI 48335

Party NameOCUPHIRE PHARMA, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFarmington Hills, MI 48335

Trademark Events


Event DateEvent Description
Tuesday, October 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 13, 2022NEW APPLICATION ENTERED
Monday, July 24, 2023ASSIGNED TO EXAMINER
Friday, July 28, 2023NON-FINAL ACTION E-MAILED
Friday, July 28, 2023NON-FINAL ACTION WRITTEN
Friday, July 28, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 15, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 15, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, November 15, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 15, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, November 16, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 19, 2023PUBLISHED FOR OPPOSITION
Tuesday, December 19, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 13, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 29, 2024SOU TEAS EXTENSION RECEIVED
Monday, July 29, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 29, 2024SOU EXTENSION 1 FILED
Monday, July 29, 2024SOU EXTENSION 1 GRANTED